Geroscience-guided repurposing of FDA-approved drugs to target aging: a proposed process and prioritization
Islet alpha cells and glucagoncritical regulators of energy homeostasis
Hedgehog signaling and BMP4 facilitates the proliferation of fetal HPCs in vitro (Hirose et al., 2009
Common effects: Moderate appetite increase (less acute and intense than GHRP-6) Flushing and warmth at the injection site or face Transient drowsiness, particularly with evening doses Mild water retention and peripheral edema Increased gastrointestinal motility Less common: Moderate cortisol and ACTH elevation (comparable to hCRH per Arvat et al.) Mild prolactin elevation Numbness or tingling in extremities (GH-mediated fluid shifts) Joint stiffness at higher doses Lightheadedness post-injection Potential tachyphylaxis: Bowers and colleagues noted response attenuation after five consecutive days of GHRP-2 injections, reinforcing the rationale for periodic cycling breaks rather than continuous indefinite use

Common methods include radiolabeling (attaching a detectable isotope to the compound and tracking its distribution via imaging), microdialysis (sampling interstitial fluid directly from brain tissue), and post-mortem tissue analysis measuring compound concentrations in specific brain regions
Soni and Salh (539) revealed that curcumin effectively inhibits platelet aggregation and prevents blood clot formation